Back to News
Market Impact: 0.2
Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Source: WIRED
Artificial IntelligenceHealthcare & BiotechPrivate Markets & VentureTechnology & Innovation
UK government-backed startup Potential Sciences is betting that training AI models on computer-generated biochemical data can accelerate drug development. The article provides no performance results, funding amount, or development timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- Magnificent 7 loses $1 trillion. The most eye-popping stats from Thursday's tech stock plunge
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Wall Street’s best post-midterm rally in 44 years lasted just one day—then $3 trillion vanished as chip stocks plunged over AI fears
- How Wall Street's postelection rally got obliterated — and what's next
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- AI stocks plunge after election, driving down US markets